UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disease-modifying treatments for multiple sclerosis - a review of approved medications

European journal of neurology, 2016-01, Vol.23 (S1), p.18-27

2016

Volltextzugriff (PDF)

Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy

European journal of neurology, 2018-03, Vol.25 (3), p.527-534

2018

Volltextzugriff (PDF)

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-10, Vol.374 (9700), p.1503-1511

2009

Volltextzugriff (PDF)

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades

Acta neurologica Scandinavica, 2015-07, Vol.132 (S199), p.29-36

2015

Volltextzugriff (PDF)

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis

European journal of neurology, 2015-02, Vol.22 (2), p.328-333

2015

Volltextzugriff (PDF)

The cuprizone model for demyelination

Acta neurologica Scandinavica, 2008-05, Vol.117 (s188), p.72-76

2008

Volltextzugriff (PDF)

Health related quality of life in patients recently diagnosed with multiple sclerosis

Acta neurologica Scandinavica, 2014-01, Vol.129 (1), p.21-26

2014

Volltextzugriff (PDF)

IL-6: an early marker for outcome in acute ischemic stroke

Acta neurologica Scandinavica, 2005-06, Vol.111 (6), p.360-365

2005

Volltextzugriff (PDF)

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study

Journal of neurology, 2024-04, Vol.271 (4), p.1610-1617

2024

Volltextzugriff (PDF)

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

European journal of neurology, 2016-06, Vol.23 (6), p.1064-1070

2016

Volltextzugriff (PDF)

Month of birth as a risk factor for multiple sclerosis: an update

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.58-62

2012

Volltextzugriff (PDF)

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

European journal of neurology, 2005-11, Vol.12 (11), p.817-827

2005

Volltextzugriff (PDF)

The Norwegian Multiple Sclerosis Registry and Biobank

Acta neurologica Scandinavica, 2015-07, Vol.132 (S199), p.24-28

2015

Volltextzugriff (PDF)

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study

European journal of neurology, 2016-01, Vol.23 (1), p.168-174

2016

Volltextzugriff (PDF)

A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes

Genes and immunity, 2009-03, Vol.10 (2), p.120-124

2009

Volltextzugriff (PDF)

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

Neurology, 2005-12, Vol.65 (12), p.1961-1963

2005

Volltextzugriff (PDF)

Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis

Multiple sclerosis, 2007-01, Vol.13 (1), p.106-112

2007

Volltextzugriff (PDF)

Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review

Acta neurologica Scandinavica, 2013-01, Vol.127 (s196), p.24-30

2013

Volltextzugriff (PDF)

The economic impact of multiple sclerosis to the patients and their families in Norway

The European journal of health economics, 2018-12, Vol.19 (9), p.1243-1257

2018

Volltextzugriff (PDF)

The Norwegian Multiple Sclerosis Registry and Biobank

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.20-23

2012

Volltextzugriff (PDF)

Pain and sensory complaints in multiple sclerosis

European journal of neurology, 2004-07, Vol.11 (7), p.479-482

2004

Volltextzugriff (PDF)

Corticosteroids in the treatment of multiple sclerosis

Acta neurologica Scandinavica, 2009-08, Vol.120 (s189), p.73-80

2009

Volltextzugriff (PDF)

Polyunsaturated fatty acids in multiple sclerosis therapy

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.70-75

2012

Volltextzugriff (PDF)

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore

Acta neurologica Scandinavica, 2012-12, Vol.126 (s195), p.63-69

2012

Volltextzugriff (PDF)

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)

Acta neurologica Scandinavica, 2012, Vol.126 (s195), p.43-50

2012

Volltextzugriff (PDF)

1 – 25 von 224

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(203)

Publikationsform

Sprache

Englisch
(220)
Norwegisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Disease-modifying treatments for multiple sclerosis - a review of approved medications

Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades

Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis

The cuprizone model for demyelination

Health related quality of life in patients recently diagnosed with multiple sclerosis

IL-6: an early marker for outcome in acute ischemic stroke

Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

Month of birth as a risk factor for multiple sclerosis: an update

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

The Norwegian Multiple Sclerosis Registry and Biobank

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study

A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes

Pregnancy, delivery, and birth outcome in women with multiple sclerosis

Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis

Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review

The economic impact of multiple sclerosis to the patients and their families in Norway

The Norwegian Multiple Sclerosis Registry and Biobank

Pain and sensory complaints in multiple sclerosis

Corticosteroids in the treatment of multiple sclerosis

Polyunsaturated fatty acids in multiple sclerosis therapy

Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)

Suchergebnisse filtern